Evidence supports the use of MRI for men at risk of harbouring prostate cancer and who have not undergone a previous biopsy and in men with an increased prostate specific antigen following an initial negative standard prostate biopsy procedure [131]. The gene discussed is KLK3; the disease is prostate cancer.